1st Quarter - Report
STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED
Firm
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
issues related to rare and orphan disease therapeutics; issues related to FDA regulatory pathways for pharmaceuticals; awareness of cystic fibrosis; promoting reimbursement policies that protect patient access to pharmaceuticals; reauthorization of the Prescription Drug User Fee Amendments (PDUFA); CHIP reauthorization orphan drug provisions of HR 1, Tax Cuts and Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | — |
| SARAH HAMLETT | Legislative Director, Rep. Thelma Drake; Legislative Assistant, Rep. Schrock |
| VALERIE HENRY | — |
| JOSEPH RACHINSKY | — |
| EMILY SHETTY | — |
| ERIN STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.